Retinal hypoplasia and degeneration result in vision loss in Friedreich ataxia

© 2023 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association..

OBJECTIVE: Friedreich ataxia (FRDA) is an inherited condition caused by a GAA triplet repeat (GAA-TR) expansion in the FXN gene. Clinical features of FRDA include ataxia, cardiomyopathy, and in some, vision loss. In this study, we characterize features of vision loss in a large cohort of adults and children with FRDA.

METHODS: Using optical coherence tomography (OCT), we measured peripapillary retinal nerve fiber layer (RNFL) thickness in 198 people with FRDA, and 77 controls. Sloan letter charts were used to determine visual acuity. RNFL thickness and visual acuity were compared to measures of disease severity obtained from the Friedreich Ataxia Clinical Outcomes Measures Study (FACOMS).

RESULTS: The majority of patients, including children, had pathologically thin RNFLs (mean = 73 ± 13 μm in FRDA; 98 ± 9 μm in controls) and low-contrast vision deficits early in the disease course. Variability in RNFL thickness in FRDA (range: 36 to 107 μm) was best predicted by disease burden (GAA-TR length X disease duration). Significant deficits in high-contrast visual acuity were apparent in patients with an RNFL thickness of ≤68 μm. RNFL thickness decreased at a rate of -1.2 ± 1.4 μm/year and reached 68 μm at a disease burden of approximately 12,000 GAA years, equivalent to disease duration of 17 years for participants with 700 GAAs.

INTERPRETATION: These data suggest that both hypoplasia and subsequent degeneration of the RNFL may be responsible for the optic nerve dysfunction in FRDA and support the development of a vision-directed treatment for selected patients early in the disease to prevent RNFL loss from reaching the critical threshold.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:10

Enthalten in:

Annals of clinical and translational neurology - 10(2023), 8 vom: 19. Aug., Seite 1397-1406

Sprache:

Englisch

Beteiligte Personen:

Rodden, Layne N [VerfasserIn]
McIntyre, Kellie [VerfasserIn]
Keita, Medina [VerfasserIn]
Wells, Mckenzie [VerfasserIn]
Park, Courtney [VerfasserIn]
Profeta, Victoria [VerfasserIn]
Waldman, Amy [VerfasserIn]
Rummey, Christian [VerfasserIn]
Balcer, Laura J [VerfasserIn]
Lynch, David R [VerfasserIn]

Links:

Volltext

Themen:

Journal Article
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 15.08.2023

Date Revised 16.08.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1002/acn3.51830

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM358364027